What Is Sepsis?

Chapter

Abstract

Sepsis is a perplexing infection-related syndrome documented for thousands of years. It remains a leading cause of mortality and morbidity worldwide. The concepts and understanding of sepsis have evolved in recent decades from a systemic inflammatory response syndrome to infection to, more recently, a life-threatening organ dysfunction due to a dysregulated host response. Clinical recognition of sepsis is often difficult, especially in the early stages of presentation. The disease course of sepsis is also highly variable. Heterogeneity related to age, comorbidity and iatrogenic intervention add further layers of complexity. Specific and sensitive diagnostics to aid identification and guide treatment are still lacking, though novel technologies hold considerable promise. It is now recognized that the biological phenotype of sepsis varies markedly, both between patients and over time. Thus, a one-size-fits-all therapeutic approach is increasingly viewed as over-simplistic, explaining the failure of various strategies in multiple randomized controlled trials.

Keywords

Sepsis Septic shock Definition Sepsis-3 Clinical criteria 

References

  1. 1.
    Singer M, Deutschmann CS, Seymour CW, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016;315:801–10.CrossRefGoogle Scholar
  2. 2.
    Angus DC, van der Poll T. Severe sepsis and septic shock. N Engl J Med. 2013;369:840–51.CrossRefGoogle Scholar
  3. 3.
    Fleischmann C, Scherag A, Adhikari NKJ, et al. Assessment of global incidence and mortality of hospital-treated sepsis. Current estimates and limitations. Am J Respir Crit Care Med. 2016;193:259–72.CrossRefGoogle Scholar
  4. 4.
    World Health Organization. The top 10 causes of death (Fact sheet updated January 2017). http://www.who.int/mediacentre/factsheets/fs310/en/. Accessed 9 Feb 2018.
  5. 5.
    Kaukonen K-M, Bailey M, Suzuki S, et al. Mortality related to severe sepsis and septic shock among critically ill patients in Australia and New Zealand, 2000–2012. JAMA. 2014;311:1308–16.CrossRefGoogle Scholar
  6. 6.
    Rhee C, Gohil S, Klompas M. Regulatory mandates for sepsis care--reasons for caution. N Engl J Med. 2014;370:1673–6.CrossRefGoogle Scholar
  7. 7.
    Osler W. Principles and practice of medicine designed for the use of practitioners and students of medicine. 3rd ed. Edinburgh: Pentland; 1898.Google Scholar
  8. 8.
    Majno G. The ancient riddle of sigma eta psi iota sigma (sepsis). J Infect Dis. 1991;163:937–45.CrossRefGoogle Scholar
  9. 9.
    Haensch S, Bianucci R, Signoli M, et al. Distinct clones of Yersinia pestis caused the black death. PLoS Pathog. 2010;6:e1001134.CrossRefGoogle Scholar
  10. 10.
    Benedictow OJ. The black death 1346–1353: the complete history. Woodbridge: Boydell Press; 2004.Google Scholar
  11. 11.
    Davaine MC. Recherches sur quelques questions relatives a la septicemie. Paris: G. Masson; 1872.Google Scholar
  12. 12.
    Lister J. On the antiseptic principle in the practice of surgery. Lancet. 1867;90:353–6.CrossRefGoogle Scholar
  13. 13.
    Fleming A. On the antibacterial action of cultures of a Penicillium, with special reference to their use in the isolation of B. influenzæ. Br J Exp Pathol. 1929;10:226–36.PubMedCentralGoogle Scholar
  14. 14.
    Kelly FE, Fong K, Hirsch N, et al. Intensive care medicine is 60 years old: the history and future of the intensive care unit. Clin Med. 2014;14:376–9.CrossRefGoogle Scholar
  15. 15.
    Thomas L. Germs. N Engl J Med. 1972;287:553–5.CrossRefGoogle Scholar
  16. 16.
    Cerra FB. The systemic septic response: multiple systems organ failure. Crit Care Clin. 1985;1:591–607.PubMedGoogle Scholar
  17. 17.
    Fink MP, Heard SO. Laboratory models of sepsis and septic shock. J Surg Res. 1990;49:186–96.CrossRefGoogle Scholar
  18. 18.
    Bone RC, Balk RA, Cerra FB, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest. 1992;101:1644–55.CrossRefGoogle Scholar
  19. 19.
    Levy MM, Fink MP, Marshall JC, et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med. 2003;31:1250–6.CrossRefGoogle Scholar
  20. 20.
    Hotchkiss R, Karl I. The pathophysiology and treatment of sepsis. N Engl J Med. 2003;348(2):138–50.CrossRefGoogle Scholar
  21. 21.
    Mira JC, Gentile LF, Mathias BJ, et al. Sepsis pathophysiology, chronic critical illness, and persistent inflammation-immunosuppression and catabolism syndrome. Crit Care Med. 2017;XX:1–10.Google Scholar
  22. 22.
    van Vught LA, Klein Klouwenberg PMC, Spitoni C, et al. Incidence, risk factors, and attributable mortality of secondary infections in the intensive care unit after admission for sepsis. JAMA. 2016;315:1469.CrossRefGoogle Scholar
  23. 23.
    Zeni F, Freeman B, Natanson C. Anti-inflammatory therapies to treat sepsis and septic shock: a reassessment. Crit Care Med. 1997;25:1095–100.CrossRefGoogle Scholar
  24. 24.
    Angus DC. The search for effective therapy for sepsis: back to the drawing board? JAMA. 2011;306:2614–5.CrossRefGoogle Scholar
  25. 25.
    Sprung CL, Schein RMH, Balk RA. The new sepsis consensus definitions: the good, the bad and the ugly. Intensive Care Med. 2016;42:2024–6.CrossRefGoogle Scholar
  26. 26.
    Vincent JL, Moreno R, Takala J, et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the working group on sepsis-related problems of the European Society of Intensive Care Medicine. Intensive Care Med. 1996;22:707–10.CrossRefGoogle Scholar
  27. 27.
    de Grooth H-J, Geenen IL, Girbes AR, et al. SOFA and mortality endpoints in randomized controlled trials: a systematic review and meta-regression analysis. Crit Care. 2017;21:38.CrossRefGoogle Scholar
  28. 28.
    Hotchkiss RS, Moldawer LL, Opal SM, et al. Sepsis and septic shock. Nat Rev Dis Prim. 2016;2:16045.CrossRefGoogle Scholar
  29. 29.
    Rudiger A, Singer M. Mechanisms of sepsis-induced cardiac dysfunction. Crit Care Med. 2007;35:1599–608.CrossRefGoogle Scholar
  30. 30.
    Haak BW, Wiersinga WJ. The role of the gut microbiota in sepsis. Lancet Gastroenterol Hepatol. 2017;2:135–43.CrossRefGoogle Scholar
  31. 31.
    Hotchkiss RS, Swanson PE, Freeman BD, et al. Apoptotic cell death in patients with sepsis, shock, and multiple organ dysfunction. Crit Care Med. 1999;27:1230–51.CrossRefGoogle Scholar
  32. 32.
    Takasu O, Gaut JP, Watanabe E, et al. Mechanisms of cardiac and renal dysfunction in patients dying of sepsis. Am J Respir Crit Care Med. 2013;187:509–17.CrossRefGoogle Scholar
  33. 33.
    Singer M, De Santis V, Vitale D, et al. Multiorgan failure is an adaptive, endocrine-mediated, metabolic response to overwhelming systemic inflammation. Lancet (London, England). 2004;364:545–8.CrossRefGoogle Scholar
  34. 34.
    Langley RJ, Tsalik EL, van Velkinburgh JC, et al. An integrated clinico-metabolomic model improves prediction of death in sepsis. Sci Transl Med. 2013;5:195ra95.CrossRefGoogle Scholar
  35. 35.
    Stephens DS, Greenwood B, Brandtzaeg P. Epidemic meningitis, meningococcaemia, and Neisseria meningitidis. Lancet. 2007;369:2196–210.CrossRefGoogle Scholar
  36. 36.
    Heffner AC, Horton JM, Marchick MR, et al. Etiology of illness in patients with severe sepsis admitted to the hospital from the emergency department. Clin Infect Dis. 2010;50:814–20.CrossRefGoogle Scholar
  37. 37.
    Pierrakos C, Vincent J-L. Sepsis biomarkers: a review. Crit Care. 2010;14:R15.CrossRefGoogle Scholar
  38. 38.
    Davenport EE, Burnham KL, Radhakrishnan J, et al. Genomic landscape of the individual host response and outcomes in sepsis: a prospective cohort study. Lancet Respir Med. 2016;4:259–71.CrossRefGoogle Scholar
  39. 39.
    Angus DC, Linde-Zwirble WT, Lidicker J, et al. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med. 2001;29:1303–10.CrossRefGoogle Scholar
  40. 40.
    van Vught LA, Holman R, de Jonge E, et al. Diabetes is not associated with increased 90-day mortality risk in critically ill patients with sepsis. Crit Care Med. 2017;45(10):e1026–35.  https://doi.org/10.1097/CCM.0000000000002590.CrossRefPubMedGoogle Scholar
  41. 41.
    Wan Y-D, Sun T-W, Kan Q-C, et al. Effect of statin therapy on mortality from infection and sepsis: a meta-analysis of randomized and observational studies. Crit Care. 2014;18:R71.CrossRefGoogle Scholar
  42. 42.
    Morelli A, Ertmer C, Westphal M, et al. Effect of heart rate control with esmolol on hemodynamic and clinical outcomes in patients with septic shock. JAMA. 2013;310:1683.CrossRefGoogle Scholar
  43. 43.
    Wiewel MA, van Vught LA, Scicluna BP, et al. Prior use of calcium channel blockers is associated with decreased mortality in critically ill patients with sepsis: a prospective observational study. Crit Care Med. 2017;45:454–63.CrossRefGoogle Scholar
  44. 44.
    Arabi YM, Dara SI, Tamim HM, et al. Clinical characteristics, sepsis interventions and outcomes in the obese patients with septic shock: an international multicenter cohort study. Crit Care. 2013;17:R72.CrossRefGoogle Scholar
  45. 45.
    Gentile LF, Cuenca AG, Efron PA, et al. Persistent inflammation and immunosuppression: a common syndrome and new horizon for surgical intensive care. J Trauma Acute Care Surg. 2012;72:1491–501.CrossRefGoogle Scholar
  46. 46.
    Angus DC, Carlet J. Surviving intensive care: a report from the 2002 Brussels Roundtable. Intensive Care Med. 2003;29:368–77.CrossRefGoogle Scholar
  47. 47.
    Mehlhorn J, Freytag A, Schmidt K, et al. Rehabilitation interventions for postintensive care syndrome: a systematic review. Crit Care Med. 2014;42:1263–71.CrossRefGoogle Scholar
  48. 48.
    Hutchins NA, Unsinger J, Hotchkiss RS, et al. The new normal: immunomodulatory agents against sepsis immune suppression. Trends Mol Med. 2014;20:224–33.CrossRefGoogle Scholar
  49. 49.
    Daviaud F, Grimaldi D, Dechartres A, et al. Timing and causes of death in septic shock. Ann Intensive Care. 2015;5:16.CrossRefGoogle Scholar
  50. 50.
    Zolfaghari PS, Pinto BB, Dyson A, et al. The metabolic phenotype of rodent sepsis: cause for concern? Intensive Care Med Exp. 2013;1:6.CrossRefGoogle Scholar
  51. 51.
    Lockhart PB, Brennan MT, Sasser HC, et al. Bacteremia associated with tooth brushing and dental extraction. Circulation. 2008;117:3118–25.CrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Bloomsbury Institute of Intensive Care MedicineUniversity College LondonLondonUK

Personalised recommendations